Skip to main content
. 2021 Oct 12;50(3):398–409. doi: 10.1097/CCM.0000000000005229

Table 1.

Biomarker Levels at Baseline (Modified Intention-to-Treat Population)

Biomarker Normal Range Placebo Tocilizumab
Interleukin-6, ng/mLa ≤ 0.007 n = 99 n = 233
 Mean (sd) 192.2 (368.7) 201.9 (418.4)
 Median (range) 70.3 (3.1–2,810) 88.1 (3.1–4,020)
C-reactive protein, mg/L ≤ 5 n = 126 n = 256
 Mean (sd) 177.8 (117.1) 187.8 (119.8)
 Median (range) 151.9 (1.6–500) 169.3 (1.1–500)
Ferritin, pmol/La 27 to ≤ 337 (women) n = 124 n = 240
 Mean (sd) 27 to ≤ 674 (men) 3,792 (7,463) 3,069 (3,113)
 Median (range) 2,168 (96.9–75,300) 2,250 (3.6–24,045)
d-dimer, μg/mL fibrinogen equivalent unitsa ≤ 0.5 n = 66 n = 131
 Mean (sd) 4.2 (7.6) 4.6 (8.4)
 Median (range) 1.2 (0.3–46.7) 1.3 (0.2–58.1)
Lactate dehydrogenase, IU/L 105–333 n = 121 n = 243
 Mean (sd) 469.7 (291.7) 479.4 (303.5)
 Median (range) 422 (1.3–2,323) 430 (0.7–3,282)
Leukocytes, 109/La 4.5–11 n = 140 n = 280
 Mean (sd) 9.2 (4.1) 9.3 (4.5)
 Median (range) 8.5 (2.4–22.4) 8.3 (2.7–28.2)
Lymphocytes, 109/La 0.9–2.9 n = 139 n = 288
 Mean (sd) 0.96 (0.83) 0.98 (0.57)
 Median (range) 0.9 (0–8.9) 0.9 (0–5.4)
Lymphocytes, % 20–40 n = 133 n = 268
 Mean (sd) 13 (10) 12 (7)
 Median (range) 11 (0–55) 11 (0–48)
Neutrophils, 109/L 1.7–7 n = 139 n = 291
 Mean (sd) 7.5 (3.9) 7.6 (4.1)
 Median (range) 7.2 (0.9–23.1) 6.8 (1.0–24.6)
Neutrophils, % 40–60 n = 134 n = 268
 Mean (sd) 79 (12) 79 (9)
 Median (range) 82 (24–98) 81 (44–99)
Neutrophils/lymphocytes, ratioa 1–3 n = 132 n = 265
 Mean (sd) 65.0 (566.5) 64.8 (683.6)
 Median (range) 7.1 (0.4–6,509) 7.5 (1.2–10,463)
Monocytes, % 2–8 n = 131 n = 269
 Mean (sd) 6 (4) 6 (4)
 Median (range) 5 (0–19) 5 (0–32)
Platelets, 109/L 150–400 n = 142 n = 295
 Mean (sd) 262.0 (117.7) 265.7 (113.3)
 Median (range) 240 (53–814) 253 (10.2–825)

aLog-transformed for all additional analyses.